MU Comparative Oncology

We had an extra spooky graduation today for this cowboy cutie! Gizmo graduated from radiation therapy in August, and today he graduated from chemotherapy! His smile says it all! Congratulations Gizmo, we are so proud of you 🎉🎃

Meet Louie! This handsome man completed his chemotherapy protocol yesterday, so of course we had to celebrate him! Louie started chemotherapy in March for his metastatic carcinoma, and he has come such a long way since then. We are so happy for you Louie! 🎉🐾

We are excited to announce a new clinical trial investigating the use of a novel radio-tracer (Copper-64) for PET imaging of cats diagnosed with mammary carcinoma!

Feline mammary carcinoma is the third most common cancer in cats. Similar to certain subtypes of breast cancer in humans, it has an aggressive biologic behavior, high risk of metastatic disease, and limited systemic treatment options.

We hope to use the information gained in this study to develop new systemic treatment options for cats diagnosed with mammary carcinoma in the future. Please see below for additional information on the study and use the provided link to fill out a survey to see if your cat qualifies.

https://missouri.qualtrics.com/jfe/form/SV_9WYc2JsTg3WRGiW